New collaborative “service innovation” ethos the key to NHS high-value eqpt management
This article was originally published in Clinica
The UK healthcare industry’s initial responses to this week’s parliamentary Public Accounts Committee (PAC) report on managing high-value capital equipment in the NHS in England have revealed the complexity of the issues at hand.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
An AAM-sponsored study by researcher Avalere Health has concluded that Medicare Part D policy changes have led to generics being placed on non-generic tiers 53% of the time in 2020, with generics placed on the ‘preferred generic’ Tier 1 just 10% of the time.